Sidney Laura E, Branch Matthew J, Dua Harminder S, Hopkinson Andrew
Academic Ophthalmology, Division of Clinical Neuroscience, Queen's Medical Centre Campus, University of Nottingham, Nottingham, United Kingdom.
Academic Ophthalmology, Division of Clinical Neuroscience, Queen's Medical Centre Campus, University of Nottingham, Nottingham, United Kingdom.
Cytotherapy. 2015 Dec;17(12):1706-22. doi: 10.1016/j.jcyt.2015.08.003. Epub 2015 Oct 9.
The limbal area of the corneal stroma has been identified as a source of mesenchymal-like stem cells, which have potential for exploitation as a cell therapy. However, the optimal culture conditions are disputed and few direct media comparisons have been performed. In this report, we evaluated several media types to identify the optimal for inducing an in vitro stem cell phenotype.
Primary human corneal stroma-derived stem cells (CSSCs) were extracted from corneoscleral rims. Culture in seven different media types was compared: Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS); M199 with 20% FBS; DMEM-F12 with 20% serum replacement, basic fibroblast growth factor and leukemia inhibitory factor (SCM); endothelial growth medium (EGM); semi-solid MethoCult; serum-free keratinocyte medium (K-SFM); and StemPro-34. Effects on proliferation, morphology, protein and messenger RNA expression were evaluated.
All media supported proliferation of CSSCs with the exception of K-SFM and StemPro-34. Morphology differed between media: DMEM produced large cells, whereas EGM produced very small cells. Culture in M199 produced a typical mesenchymal stromal cell phenotype with high expression of CD105, CD90 and CD73 but not CD34. Culture in SCM produced a phenotype more reminiscent of a progenitor cell type with expression of CD34, ABCG2, SSEA-4 and PAX6.
Culture medium can significantly influence CSSC phenotype. SCM produced a cell phenotype closest to that of a pluripotent stem cell, and we consider it to be the most appropriate for development as a clinical-grade medium for the production of CSSC phenotypes suitable for cell therapy.
角膜基质的角膜缘区域已被确定为间充质样干细胞的来源,这些干细胞具有作为细胞疗法加以利用的潜力。然而,最佳培养条件存在争议,且很少有直接的培养基比较研究。在本报告中,我们评估了几种培养基类型,以确定诱导体外干细胞表型的最佳培养基。
从角膜缘提取原代人角膜基质衍生干细胞(CSSCs)。比较在七种不同培养基类型中的培养情况:含10%胎牛血清(FBS)的杜氏改良 Eagle 培养基(DMEM);含20% FBS的M199;含20%血清替代物、碱性成纤维细胞生长因子和白血病抑制因子的DMEM-F12(SCM);内皮细胞生长培养基(EGM);半固体甲基纤维素培养基;无血清角质形成细胞培养基(K-SFM);以及StemPro-34。评估对增殖、形态、蛋白质和信使核糖核酸表达的影响。
除K-SFM和StemPro-34外,所有培养基均支持CSSCs的增殖。不同培养基中的形态有所不同:DMEM培养出的细胞较大,而EGM培养出的细胞非常小。在M199中培养产生了典型的间充质基质细胞表型,CD105、CD90和CD73表达高,但CD34不表达。在SCM中培养产生的表型更类似于祖细胞类型,表达CD34、ABCG2、SSEA-4和PAX6。
培养基可显著影响CSSC表型。SCM产生的细胞表型最接近多能干细胞,我们认为它最适合开发为临床级培养基,用于生产适合细胞治疗的CSSC表型。